Hereditary Angioedema | Rare Disease Hub

This is a promotional website intended for UK healthcare professionals only, developed and funded by Takeda.
Details on how to report adverse events are found at the bottom of this page.

Resources

You are viewing . Change therapy area preferences.

Explore a variety of curated resources by interacting with the filters below.

article

Real World Effectiveness of Lanadelumab Tile Image

Real-world effectiveness of lanadelumab in hereditary angioedema: Interim results from a UK cohort study

treatments

TAKHZYRO® (lanadelumab)

treatments

FIRAZYR® (icatibant)

treatments

CINRYZE® (human c1-esterase inhibitor)